Clinical trials
Phase 3 Leukemia trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2012 | 2 |
| 2016 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 6 |
| Daiichi Sankyo | 2 |
| Ariad Pharmaceuticals | 1 |
| Gilead Sciences | 1 |
| Kura Oncology, Inc. | 1 |
| Mats Heyman | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 12 |
| Leukemia, Myeloid, Acute | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Leukemia, Erythroblastic, Acute | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Megakaryoblastic, Acute | 2 |
| Leukemia, Monocytic, Acute | 2 |
| Leukemia, Myelomonocytic, Acute | 2 |
| Lymphoma | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.